Important Safety Note: At Formation, we exclusively utilize human-grade medications sourced from compounding pharmacies
Ceramide-based formulas help repair the skin barrier without heavy occlusive ingredients
Ear and her colleagues encourage patients with neuroendocrine cancer to talk with their doctors before using a GLP-1 receptor agonist.
In one landmark trial that followed more than 17,000 people for more than six years, GLP-1 drugs reduced the risk of heart attack, stroke and cardiovascular death by 20% among adults with overweight or obesity and cardiovascular disease
While semaglutide is being tested for this new application, it already has FDA approval for conditions like type 2 diabetes and weight management, indicating its safety for those uses
We present a consanguineous couple with two siblings in consecutive pregnancies with LNF of CPT II deficiency who exhibited similar symptoms, both antenatally and postnatally